A Finnish study linked protein sources with small testosterone differences. See the findings, limitations and clinical context without diet promises.
On 9 September 2026, researchers at the University of Eastern Finland published a study in the International Journal of Food Sciences and Nutrition examining dietary protein sources and testosterone concentrations in middle-aged men. The university highlighted the findings in a news release on 28 October. The question connected something familiar on the plate with something measured in a blood sample.
The findings attracted attention because animal and plant protein showed associations in opposite directions. Understanding that pattern requires looking beyond the broad categories to the study design and the individual protein sources involved.
According to the university's report, the researchers analysed data from 2,546 men aged 42 to 60 who lived in eastern Finland. They used four-day food records collected between 1984 and 1989 alongside blood measurements of total testosterone and sex hormone-binding globulin, usually shortened to SHBG.
This was a cross-sectional analysis of existing data. Its central comparison was between men with different recorded protein intakes and their measured hormone concentrations.
The dietary information allowed the researchers to examine animal protein and plant protein as broad categories. They also looked more closely at particular sources, including dairy and meat. Within plant protein, they distinguished vegetables and other non-cereal sources from cereal products.
The analyses accounted for age and body mass index. They also took other dietary, lifestyle and health-related factors into account. Those adjustments are important context for interpreting the reported comparisons.
The distinction between the broad categories and the detailed results matters throughout this study. “Animal protein” was an overall grouping, while the more specific analyses asked whether different foods within that grouping showed the same pattern.
The university reported opposing associations for total animal and plant protein intake. In comparisons between the highest and lowest intake groups:
These figures describe differences between groups. Each comparison used the lowest-intake group for that particular protein category as its reference.
The more detailed findings were less uniform than a simple contrast between plants and animal foods might suggest. According to the university's account:
That meat-protein result is especially important to retain. The broad animal-protein finding should not be rewritten as a claim that meat was associated with lower total testosterone in the detailed analysis.
Likewise, the more specific plant-protein result concerned particular sources. Keeping those distinctions intact gives readers a more accurate account than treating every animal food or every plant food as interchangeable.
The university described the reported differences as statistically significant. Their size and possible meaning for health require a separate look.
The central limitation is the cross-sectional design. The researchers compared existing intake groups rather than testing whether changing someone's protein sources changed their testosterone. The findings therefore establish associations, not cause and effect.
Although the analyses included several adjustments, the researchers cautioned that other aspects of diet or metabolic factors might help explain the pattern. Accounting for measured differences between participants does not settle which factor produced an association. The study also could not determine whether protein sources affected testosterone production or its effects in the body.
The age and setting of the data matter for applying the findings. The dietary records came from an earlier period and covered a brief recording window. The participants were middle-aged men from eastern Finland, so the analysis does not establish the same pattern in women or in other age groups or populations.
University of Eastern Finland doctoral researcher Miika Wynne-Ellis described the observed hormone differences as relatively small. The researchers could not establish whether those differences had health implications. Statistical significance and clinical importance are therefore separate issues in interpreting this report.
Finally, the study measured total testosterone and SHBG rather than sexual desire or function. It did not establish improvements in libido or erections. Changes in arousal, sexual confidence and intimacy were not demonstrated outcomes either.
These uncertainties belong together: the analysis identified a dietary pattern in relation to blood measurements, while leaving its cause and personal health significance unresolved.
The most useful comparison is with established clinical guidance on assessing low testosterone. The European Association of Urology treats late-onset hypogonadism as a diagnosis requiring compatible symptoms alongside consistently low testosterone. A hormone result in isolation is not the complete assessment.
The association's guidance recommends morning and fasting testosterone measurements. It also calls for confirmation of a low result on a separate occasion before making a diagnosis or starting testosterone therapy. These are features of a clinical evaluation, not a way to interpret dietary intake groups.
That framework addresses a different question from the Finnish analysis. The researchers asked how recorded protein intake related to hormone concentrations across a group of men. Clinical assessment asks whether a particular person's symptoms and biochemical findings meet the requirements for a diagnosis.
A difference between group averages and an individual diagnosis are therefore not interchangeable. The study's reference point was another intake group. The guideline's reference point is a person's clinical presentation together with appropriately assessed blood results.
Read alongside the guidance, the Finnish study adds a specific research question about diet and hormone biology. It does not replace the framework used to assess a person with symptoms. This is how an interesting nutritional finding can contribute to the evidence without becoming a new standard for clinical care.
The practical takeaway is restraint rather than a testosterone-focused menu. This analysis is not a sound basis for making a major protein change specifically to improve sexual health. It is better understood as a finding that deserves further investigation.
There is also no need to turn the broad categories into a judgment about an entire diet. The detailed results themselves resist that approach. Keeping the actual findings attached to their specific protein sources is more useful than labelling animal protein as uniformly unfavourable or plant protein as uniformly beneficial for testosterone.
For readers interested in nutrition, the wider distinction between eating patterns and sexual-health promises offers a useful companion to this report. A dietary headline can be worth reading without becoming a reason to reorganise meals around a hormone claim.
For men concerned about a persistent sexual change, the more relevant starting point is the experience itself. A discussion with a qualified clinician can focus on what has changed and whether an assessment is appropriate. The EAU framework places that discussion in a clinical context rather than making food intake a substitute for evaluation.
Useful questions for such a conversation include whether the concern involves desire or erections and how persistent it has been. Another is what role appropriate testing would have in understanding the concern. These questions keep attention on the person's experience rather than assuming the study has identified an explanation.
Related reading on desire during midlife can provide additional educational context. A concern about desire deserves language that describes it clearly, rather than being translated immediately into a presumed testosterone problem.
Back at the plate, the most useful change is in how the headline is read: as a question about diet and hormone biology, rather than a verdict on a meal or on someone's sexual wellbeing.
Reading a testosterone difference without mistaking it for a libido improvement is a clearer outcome, supported by Sexential's evidence-aware approach to sexual wellness. Its articles address uncertainty about changing desire and arousal for adults aged 35 to 65 by explaining hormonal findings in everyday terms without offering personalised medical advice.
Follow Sexential for thoughtful guidance on desire, sexual function, hormones, confidence, relationships and intimacy. Explore new articles and evidence-aware resources for sexual wellbeing across adulthood.
A practical guide to discussing intimacy outside sexual moments, with sample questions, listening prompts and a way to agree on a follow-up.
An analysis of 997 FDA reports describes varied sexual symptoms and timing with fluoxetine. Read the findings alongside recent UK safety communication.
Understand possible changes in comfort, erections, orgasm and recovery with age, individual variation, and when a concern deserves professional attention.
Explore practical resources on desire, function, hormones, confidence, intimacy and sexual wellbeing.
Read the Blog
